Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54253, first published .
Improvements in Adolescents’ Disordered Eating Behaviors in a Collaborative Care Digital Mental Health Intervention: Retrospective Observational Study

Improvements in Adolescents’ Disordered Eating Behaviors in a Collaborative Care Digital Mental Health Intervention: Retrospective Observational Study

Improvements in Adolescents’ Disordered Eating Behaviors in a Collaborative Care Digital Mental Health Intervention: Retrospective Observational Study

Original Paper

1Bend Health Inc, Madison, WI, United States

2FitMinded Inc LLC, Phoenix, AZ, United States

*these authors contributed equally

Corresponding Author:

Darian Lawrence-Sidebottom, PhD

Bend Health Inc

2810 Marshall Ct

Madison, WI, 53705

United States

Phone: 1 8005160975

Email: darian.lawrence@bendhealth.com


Background: Young people today are exhibiting increasing rates of disordered eating behaviors, as well as eating disorders (EDs), alongside other mental and behavioral problems such as anxiety and depression. However, limited access to mental health care means that EDs, disordered eating behaviors, and comorbid mental health problems are often underdiagnosed and undertreated. Digital mental health interventions (DMHIs) offer accessible and scalable alternatives to traditional treatment modalities, but their effectiveness has not been well established among adolescents with EDs and disordered eating behaviors.

Objective: This study uses data from a collaborative care pediatric DMHI to determine whether participation in a DMHI is associated with a reduction in adolescents’ disordered eating behaviors.

Methods: Adolescent members in care with Bend Health Inc completed the SCOFF questionnaire at baseline (before the start of care) and approximately every month during care to assess disordered eating behaviors. They also completed assessments of mental health symptoms at baseline. Member characteristics, mental health symptoms, and disordered eating behaviors of adolescents with elevated SCOFF scores at baseline (before the start of care) were compared to those of adolescents with nonelevated SCOFF scores at baseline. Members participated in web-based coaching or therapy sessions throughout the duration of mental health care.

Results: Compared to adolescents with nonelevated SCOFF scores (n=520), adolescents with elevated SCOFF scores (n=169) were predominantly female and exhibited higher rates of elevated anxiety and depressive symptoms. SCOFF scores decreased over time in care with the DMHI for 61.4% (n=70) of adolescents with elevated SCOFF scores, and each additional month of participation was associated with greater improvements in disordered eating behaviors (F1,233=72.82; P<.001).

Conclusions: Our findings offer promising preliminary evidence that participation in mental health care with a collaborative care DMHI may be beneficial in the reduction of disordered eating symptoms in adolescents, including those who are experiencing comorbid anxiety and depressive symptoms.

JMIR Form Res 2024;8:e54253

doi:10.2196/54253

Keywords



Eating disorders (EDs) and associated disordered eating behaviors impact approximately 10% of the US population [1]. The peak age of onset of EDs such as anorexia nervosa, bulimia nervosa, avoidant or restrictive food intake disorder, and binge ED is between 13 and 18 years, making them particularly relevant during adolescence. Estimates of EDs in adolescence range from 1.2% among males to 5.7% in females and 9% among sexual and gender nonconforming youths [2-5]. Disordered eating behaviors (eg, obsessing over food intake and excessive worry about weight) are even more common, impacting nearly 1 in 4 children and adolescents [6]. EDs and disordered eating behaviors disrupt critical periods of physical and socioemotional development that occur during childhood and adolescence [7]. Youths with EDs experience compromised physical functioning such as malnutrition, disrupted pubertal development, and delayed menarche, as well as worsened psychosocial functioning. EDs are highly comorbid with, and often preceded by, other mental health problems such as anxiety or anxiety disorders, depression, and obsessive-compulsive disorder [8].

During the COVID-19 pandemic, the prevalence of EDs more than doubled among adolescents, exacerbating an already pressing public health issue [9,10]. Indeed, EDs confer a significant economic burden for families and hospitals, with an estimated annual disease burden of US $70 billion [11,12]. However, more than 75% of those with EDs or risk for EDs do not receive the necessary treatment [13]. Several issues underlie this gap between ED diagnosis and treatment. ED treatments are often difficult to access, especially for young people, who often experience financial, geographic, and transportation constraints as well as increased stigma [14]. Additionally, in-person services, such as inpatient and outpatient care and face-to-face therapy, are severely limited in their accessibility, largely due to shortages of trained personnel and long waitlists [14].

In recent years, digital mental health interventions (DMHIs) such as self-guided applications and web-based therapy have emerged as accessible and scalable alternatives to traditional mental health treatments. Several systematic reviews and meta-analyses suggest the potential for DMHIs in ED treatment, although results remain heterogeneous and inconclusive [15]. Moreover, few studies of DMHIs for EDs have been conducted among adolescents, despite the pressing need for accessible child and adolescent ED treatments. As argued by Loucas et al [16], most pediatric DMHIs for EDs are more similar to web-based self-help programs than therapeutic interventions, given their lack of personalized and interactive components [17-19]. However, recent advances in pediatric DMHIs using family-based therapy for ED treatment have yielded promising results, suggesting that digital ED treatments for youths are most effective when administered in the context of a holistic care team [20-22].

The collaborative care model is a team-based framework for mental health care that has been used by DMHIs with promising results. In the collaborative care model, primary care providers collaborate with behavioral care managers (BCM) and other providers to implement measurement-based mental health care. Collaboration between providers reduces the burden on primary care providers while ensuring optimal, evidence-based care via regular symptom assessments. As a result, interventions that use collaborative care models are particularly effective for the treatment of mental health problems in both youths and adults [23-26]. However, no studies to date have evaluated whether participation in collaborative care DMHIs may improve disordered eating behaviors among adolescents. As such, the purpose of this study was to use retrospective analyses of data collected from adolescents participating in care with a collaborative care DMHI to determine whether participation in a pediatric collaborative care DMHI is associated with a reduction in disordered eating behaviors. Considering established demographic and clinical correlates of disordered eating behaviors we also explored associations between potential confounds (age, sex, and anxiety and depressive symptoms) and disordered eating behaviors among those receiving care with the DMHI.


Design and Participants

All adolescents (ages 13-17 years) who met the following inclusion criteria were eligible for inclusion in the study (N=689): (1) started mental health care (first synchronous event) with Bend Health Inc between January 1, 2023, and October 1, 2023 (9 months); (2) had at least 1 synchronous session with a Bend Health Inc coach or therapist during the study time frame; and (3) completed the assessment of eating behaviors before the start of care (baseline).

Treatment

Bend Health Inc is a DMHI that provides behavioral care for adolescents (aged 13-17 years), using a whole-family approach (ie, caregivers are closely involved in care), via a web-based platform. Bend Health Inc’s behavioral care has been described elsewhere [24,25]. Members enroll via referral from a health care provider, or they use insurance, employer benefits, or self-pay. Members are assigned a BCM, who conducts an initial evaluation of the member’s mental health concerns and circumstances, and they continue to monitor the member’s care while they are enrolled in the program. BCMs assign members a coach, and also a therapist in some cases, based on their mental health symptoms (eg, type and acuity), goals for treatment, and insurance coverage; therapists tend to be assigned only to members with more severe symptoms and conditions, whereas nearly all members are assigned a coach. Members with higher symptom acuity or a psychiatric referral may also be assigned a prescribing psychiatric practitioner (eg, a medical doctor or psychiatric nurse practitioner). In synchronous video-based coaching and therapy sessions, Bend Health Inc’s practitioners guide members and their caregivers through structured care programs. These care programs are designed to deliver evidence-based tools and techniques that target common mental and behavioral health issues such as anxiety, depression, and body image. Most care programs are designed to be completed in approximately 3 months, and some care programs (eg, the body image program) are designed to be completed in a shorter amount of time. Once a month, caregivers and adolescent members are asked to complete validated web-based assessments of the adolescent’s mental health symptoms (see Measures section). Caregivers are required to be in the same general location for their adolescents’ synchronous sessions with a coach or therapist for safety purposes.

Measures

Demographic and health information of adolescent participants is gathered during enrollment with Bend Health Inc. Caregivers respond to basic demographic questions, providing their adolescent member’s date of birth, sex at birth (male, female, or others), gender identity (male, female, transgender, nonbinary, or others), and race or ethnicity. Details on the race or ethnicity response options are included in Multimedia Appendix 1.

In addition, at enrollment, caregivers and adolescent members complete a series of symptom screening questions and validated assessments to identify common mental and behavioral health concerns. To assess eating behaviors, all adolescent members complete the SCOFF (Cronbach α=.48) [27,28]. The SCOFF is a validated questionnaire, in which the member responds “yes” or “no” to 5 items about disordered eating behaviors that they might have. The 5 items, which each correspond with a letter of the SCOFF name, are as follows: (1) Do you make yourself sick because you feel uncomfortably full? (2) Do you worry that you have lost control over how much you eat? (3) Have you recently lost more than one stone (14 lb) in a 3-month period? (4) Do you believe yourself to be fat when others say you are too thin? and (5) Would you say that food dominates your life?

To identify members with elevated anxiety and depressive symptoms, caregivers of adolescent members respond to 5 screening questions drawn from the Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition, Text Revision (DSM-5-TR) Cross-Cutting Symptom Measure [29]. For anxiety, the caregivers and adolescents together respond to the following questions: Over the last 2 weeks, how often have you been bothered by any of the following problems? (1) Feeling nervous, anxious, or on edge? and (2) Not being able to stop or control worrying? For depressive symptoms, caregivers and teens responded to the items: Over the last 2 weeks, how often have you been bothered by any of the following problems? (1) Had less fun doing things than you used to? and (2) Felt sad or depressed for several hours? Best-fit responses are selected from a 4-item Likert-type scale, with responses ranging from “not at all” (item score=0) to “nearly every day” (item score=3). Screener scores are calculated by aggregating all item scores for each screener.

Members who have an anxiety screener score of 2 or more are prompted to complete the Generalized Anxiety Disorder-7 (GAD-7) assessment (Cronbach α=.91) [30,31], and members who have a depressive screener score of 2 or more are prompted to take the Patient Health Questionnaire-9 for Adolescents (PHQ-9A; Cronbach α=.85) [32,33]. The GAD-7 has 7 questions regarding symptoms of anxiety in the prior 2 weeks with the same Likert-type scale as used in the screener questions (“not at all” to “nearly every day”). The PHQ-9A is a modified version of the PHQ-9 for adolescents aged 11-17 years. The original measure has 9 questions, but we omit a question regarding suicide and self-harm (ie, the PHQ-9A here includes 8 questions). The PHQ-9A asks adolescents about depressive symptoms in the prior week using the same Likert-type scale as in the GAD-7 and screener questions. Adolescents are asked to report their own symptoms for both GAD-7 and PHQ-9A.

Statistical Analysis

Outcome Calculations

The last assessment before the start of care (baseline) and all assessments after the start of care were considered for analysis. SCOFF scores were calculated by aggregating the number of “yes” responses, with scores ranging from 0 to 5. As has been used previously [27], members with a SCOFF score of 2 or more on their baseline assessment (ie, the last assessment before the start of care) were included in the “elevated SCOFF score” group, and members with a score of less than 2 were included in the “nonelevated SCOFF score group.” GAD-7 scores were calculated by aggregating the individual item scores. PHQ-9A scores were calculated by aggregating the individual item scores, and then, dividing by 8 and multiplying by 9 (to account for the omitted item). Members with moderate or greater severity anxiety or depressive symptoms, as determined by established criteria for the GAD-7 and PHQ-9A [29,30], were flagged as having elevated anxiety or depressive symptoms, respectively.

Baseline Characteristics: Eating Behaviors and Member Characteristics

SCOFF scores at baseline were characterized for all members, including total score and responses to individual SCOFF items. Then, member characteristics, anxiety and depressive symptom severity (elevated or nonelevated), and care participation characteristics were reported for each group and compared between groups to identify any differences. Member characteristics included age at baseline, sex (female, male, and nonbinary), gender-sex conformity (conforming and nonconforming), race or ethnicity (Asian, Black or African American, Hispanic or Latino, White, and other or multiracial), mental health condition (anxiety disorder diagnosis and depressive disorder diagnosis), and elevated mental health symptoms (anxiety and depression). The care participation metrics included the number of months in care (time between first session and last session), rates of members in coaching and therapy, and rates of members participating in the anxiety, depression, and body image care programs. Member demographics were reported by caregivers (described earlier), mental health conditions were identified from electronic health records, mental health symptoms were characterized based on symptom severity at baseline, and care participation characteristics were assessed using data from electronic health records. Age in years and months in care were compared between groups using Wilcoxon signed rank tests. All other between-group comparisons for member characteristics were performed using chi-square tests.

Change in Eating Behaviors

The number of total SCOFF assessments (ie, with baseline as the first assessment) was quantified for members in both groups. Only data from members with at least 2 assessments (baseline and at least 1 assessment after care) were included in the analyses of change in SCOFF scores (n=233 members excluded). For members in both groups, SCOFF scores at baseline and the last assessment, as well as the change in score from baseline to last assessment, were quantified. Change scores were compared to 0 using Wilcoxon signed rank test to determine whether SCOFF scores changed significantly over the course of care. The rates of members with a decrease and an increase in SCOFF score were reported for both groups to quantify rates of symptom improvement and symptom worsening, respectively. To identify which items contributed to a change in SCOFF score, “yes” responses to each item at the last assessment were reported for members who responded “yes” to the item at baseline.

Finally, a linear mixed effects model was used to test whether SCOFF scores decreased over months in care and to test whether mental health symptom severity (at baseline) and demographic factors predicted SCOFF scores. Only members with a baseline assessment within 1 month or less of the start of care were included in the linear mixed effects model (n=10 members excluded). The basic model included a fixed effect of months in care (at the time of SCOFF assessment) and a random effect of subject (member ID) on the intercept. Alternative models including one of the following predictors were tested for fit against the basic model using likelihood ratio tests: elevated anxiety symptoms at baseline (yes or no), elevated depressive symptoms at baseline (yes or no), sex at birth (female or nonfemale), age at baseline (in years), and participation in therapy (yes or no). When a likelihood ratio test was statistically significant, the predictor variable was included in the final model as a fixed effect.

Throughout, standard descriptive statistics (eg, percentages, mean and SD, and median and IQR) were used to describe the data, as appropriate. IQR values are reported as the range: 25th-75th percentile. An α level of .05 was used as the threshold of statistical significance for all analyses. Tests of normality (Kolmogorov-Smirnov and Jarque-Bera) were performed to determine appropriate statistical tests and descriptive statistics. P values were corrected for multiple tests using the Bonferroni Hoc correction statistical tests performed on baseline characteristics and change in SCOFF scores (2 sets of corrections).

Ethical Considerations

At enrollment with Bend Health Inc, all study participants provided informed consent for primary data collection (required for participation in care) and use of their data in further analyses. Given the retrospective observational nature of the study, participants were not compensated for their participation in the study. Procedures for this study were approved by the Biomedical Research Alliance of New York (Study 23-12-034-1374; approved on June 5, 2023). To ensure the privacy and confidentiality of the human participants in this study, all data (eg, from electronic health records) were deidentified prior to analysis.


Baseline Characteristics: Eating Behaviors and Member Characteristics

The distribution of baseline SCOFF scores is reported in Table 1. Ultimately, 75.5% (n=520) had nonelevated SCOFF scores, and 24.5% (n=169) had elevated SCOFF scores. For members with nonelevated SCOFF scores, 13.7% (n=71) of members responded “yes” to the item about control (item 2), and 9.2% (n=48) responded “yes” to the item about believing you are fat (item 4; Table 2). For members with elevated SCOFF scores, the most commonly reported items were loss of control (item 2: n=151, 89.3%), believing you are fat (item 4: n=113, 66.9%), and food dominating life (item 5: n=92, 54.4%).

Compared to the nonelevated SCOFF score group, the elevated SCOFF score group was more predominantly female (χ21=24.2; P<.001) and also had a higher rate of diagnoses with depressive disorders (χ21=9.5; P=.005; Table 3). Rates of elevated anxiety and depressive symptoms were higher for members with elevated SCOFF scores than members with nonelevated SCOFF scores (anxiety: χ21=31.9; P<.001 and depression: χ21=63.2; P<.001). Age, gender-sex conformity, race or ethnicity, and rates of anxiety disorder diagnoses did not differ between groups.

Members were in care for a median of 2.60 (IQR 1.27-4.23) months. In terms of participation in behavioral care, 98.8% (n=681) of all members were in coaching, and 39.8% (n=274) of all members were in therapy. Rates of participation in coaching and therapy, as well as months in care, did not differ between groups. Approximately 1 in 2 members participated in the anxiety care program, and this was similar between groups. However, participation in the depression and body image care programs was higher for members with elevated SCOFF scores versus members with nonelevated SCOFF scores (depression: χ21=15.0; P<.001).

Table 1. Distribution of SCOFF scores at baseline (N=689).
SCOFF scoreMembers, n (%)
0368 (53.4)
1152 (22.1)
2100 (14.5)
350 (7.3)
413 (1.9)
56 (0.9)
Table 2. Responses to each SCOFF item at baseline by group.
SCOFF itemNonelevated SCOFF score
(n=520), n (%)
Elevated SCOFF score
(n=169), n (%)
Do you make yourself sick because you feel uncomfortably full?13 (2.5)43 (25.4)
Do you worry that you have lost control over how much you eat?71 (13.7)151 (89.3)
Have you recently lost more than one stone (14 lb) in a 3-month period?11 (2.1)33 (19.5)
Do you believe yourself to be fat when others say you are too thin?48 (9.2)113 (66.9)
Would you say that food dominates your life?9 (1.7)92 (54.4)
Table 3. Member characteristics for each group.
Member characteristicsNonelevated SCOFF score (n=520, 75.5%)Elevated SCOFF score (n=169, 24.5%)Comparison



Chi-square (df=1)P value
Age (years), median (IQR)a15 (14-16)15 (14-16)N/Ab.87
Sex, n (%)

Female301 (57.9)134 (79.3)24.2<.001

Male212 (40.8)33 (19.5)N/AN/A

Nonbinary7 (1.3)2 (1.2)N/AN/A
Gender-sex conformity, n (%)

Conforming481 (92.5)155 (91.7)0.03.87

Nonconforming39 (7.5)14 (8.3)N/AN/A
Race or ethnicity, n (%)

Asian30 (5.8)4 (2.4)N/AN/A

Black or African American35 (6.7)15 (8.9)N/AN/A

Hispanic or Latino25 (4.8)17 (10.1)N/AN/A

White252 (48.5)87 (51.5)0.4.66

Other or multiracial178 (34.2)46 (27.2)N/AN/A
Mental health condition, n (%)

Anxiety disorder147 (28.3)56 (33.1)1.2.46

Depressive disorder35 (6.7)25 (14.8)9.4.005
Elevated mental health symptoms, n (%)

Anxiety230 (44.2)118 (69.8)31.9<.001

Depression211 (40.6)129 (76.3)63.2<.001
Duration in care (months), median (IQR)c2.51 (1.23-4.20)2.80 (1.50-4.37)N/A.28
Behavioral care participation, n (%)

Coaching513 (98.7)168 (99.4)N/AN/A

Therapy201 (38.7)73 (43.2)0.92.50
Care program, n (%)

Anxiety243 (46.7)84 (49.7)0.3.66

Depression77 (14.8)48 (28.4)15.0<.001

Body image6 (1.2)7 (4.1)N/AN/A

aBetween-group comparison was performed using a Wilcoxon signed rank test (z=–0.23).

bN/A: not applicable.

cBetween-group comparison was performed using a Wilcoxon signed rank test (z=–1.46).

Change in Eating Behaviors

SCOFF assessment counts during the study time frame are reported for each group in Table 4. For all members with a baseline and postcare assessment (ie, 2 or more total assessments), baseline assessments were completed at a median of 0.27 (IQR 0.5-0.13) months before the start of care, and the last assessments were completed at a median of 2.23 (IQR 1.1-3.6) months after the start of care. The timing of baseline and last assessments did not differ between groups (baseline: z=0.70; P=.70 and last assessment: z=–0.38; P=.70).

For members in the nonelevated SCOFF score group, 16.4% (n=56) had a decrease in SCOFF score from baseline to their last assessment, 13.7% (n=47) had an increase in SCOFF score, and 69.9% (n=239) had no change (Table 5). For members in the elevated SCOFF score group, on the other hand, 61.4% (n=70) had a decrease in SCOFF score from baseline to their last assessment, 16.7% (n=19) had an increase, and 21.1% (n=25) had no change. While SCOFF scores remained stable for the nonelevated SCOFF score group (z=–0.47; P=.70), median SCOFF scores decreased from 2 (IQR 2-3) at baseline to 1 (IQR 0-3) at the last assessment for the elevated SCOFF score group (z=–6.39; P<.001). Individual item responses at the last assessment for members who responded “yes” to the item at baseline are reported in Table 6.

In the linear mixed effects model of SCOFF score over time in care for members with elevated SCOFF scores, the following predictors were included in the final model: elevated anxiety symptoms at baseline (χ21=7.6; P=.006), elevated depressive symptoms at baseline (χ21=8.6; P=.003), and participation in therapy (χ21=4.4; P=.03). SCOFF score decreased by 0.26 points for each month in care (F1,233=72.82; P<.001; Figure 1). Members with elevated anxiety symptoms at baseline had SCOFF scores 0.40 points higher than those with nonelevated anxiety symptoms (F1,101=9.87; P=.005). Similarly, members with elevated depressive symptoms at baseline had SCOFF scores 0.43 points higher than those with nonelevated depressive symptoms (F1,101=5.40; P=.044). Participation in therapy did not relate to SCOFF score (F1,101=2.87; P=.16).

Table 4. Total assessments completed for each group.
Total assessmentsNonelevated SCOFF score
(n=520), n (%)
Elevated SCOFF score
(n=169), n (%)
1178 (34.2)55 (32.5)
2141 (27.1)44 (26)
396 (18.5)31 (18.3)
457 (11)22 (13)
525 (4.8)9 (5.3)
615 (2.9)5 (3)
7+8 (1.5)3 (1.8)
Table 5. Change in SCOFF score from baseline to last assessment for each group.

Nonelevated SCOFF score
(n=342)
Elevated SCOFF score
(n=114)
SCOFF score, median (IQR)

Baseline0 (0 to 1)2 (2 to 3)

Last0 (0 to 0)1 (0 to 3)

Change0 (0 to 0)–1 (–2 to 0)
Change in score, n (%)

Decrease56 (16.4)70 (61.4)

Increase47 (13.7)19 (16.7)
Table 6. Responses to each SCOFF item at the last assessment for members who answered “yes” to the item at baseline. Results are reported for each group.

Nonelevated SCOFF score (n=342), n/N (%)Elevated SCOFF score (n=114), n/N (%)

“Yes”“No”“Yes”“No”
Do you make yourself sick because you feel uncomfortably full?1/8 (12.5)7/8 (87.5)9/23 (39.1)14/23 (60.9)
Do you worry that you have lost control over how much you eat?21/44 (47.7)23/44 (52.3)49/102 (48)53/102 (52)
Have you recently lost more than one stone (14 lb) in a 3-month period?2/9 (22.2)7/9 (77.8)4/22 (18.2)18/22 (81.8)
Do you believe yourself to be fat when others say you are too thin?14/35 (40)21/35 (60)50/77 (64.9)27/77 (35.1)
Would you say that food dominates your life?1/6 (16.7)5/6 (83.7)34/60 (56.7)26/34 (43.3)
Figure 1. SCOFF score over months in care for members with elevated SCOFF scores. Individual scores are indicated by dark blue markers, and the linear model fit is indicated by the purple line.

Principal Results

Using retrospective analyses of data collected from adolescents participating in care with Bend Health Inc, the purpose of this study was to determine whether mental health care with a collaborative care DMHI is associated with a reduction in disordered eating behaviors while also accounting for demographic and mental health symptom covariates. Disordered eating scores decreased throughout care with the DMHI for 61.4% (n=70) of adolescents with elevated disordered eating scores at baseline, and longer participation was associated with greater reductions in scores. Elevated disordered eating behaviors at baseline were associated with female sex and elevated mental health symptoms. This study provides preliminary evidence that mental health care with a DMHI may positively affect disordered eating behaviors.

Over the course of care with the DMHI, 61.4% (n=70) of adolescents with disordered eating behaviors exhibited fewer problematic eating behaviors throughout participation. Further, each additional month in care was associated with larger improvements in disordered eating behaviors, even while controlling for elevated mental health symptoms. These findings, which suggest the effectiveness of a pediatric DMHI in mitigating symptoms of disordered eating, are especially timely, as many youths with EDs and disordered eating symptoms are unable to access adequate care via in-person modalities—a lingering effect of the COVID-19 pandemic and current mental health crisis in youths [34,35]. Moreover, these results suggest that collaborative care DMHIs may mitigate disordered eating behaviors in a relatively short time frame, with the change in disordered eating behaviors assessed within this study sample after just 2.23 (IQR 1.1-3.6) months in care. Given the complex and chronic nature of disordered eating behaviors and EDs, it is understandable that health care professionals prefer team-based, integrated behavioral care (eg, the collaborative care model used by the DMHI in this study) for the identification and treatment of EDs [36-39].

Compared to those without disordered eating behaviors, adolescent members with disordered eating behaviors were more likely to be female than male. Extant literature suggests a similar trend, namely, that females tend to report more disordered eating behaviors and higher rates of ED diagnosis than their male peers [40,41]. However, this does not mean that disordered eating is not a problem among males. In this study, 19.5% (n=33) of adolescents flagged with problematic eating behaviors were male. Disordered eating behaviors may go underreported and unrecognized in males due to stigma [42], and ED diagnostic criteria may not accurately capture disordered eating behaviors that are more prevalent in males than females, such as preoccupation with gaining muscle mass and fear of losing weight [43,44]. Mental health providers and practitioners in both traditional and web-based modalities should continue to screen for disordered eating behaviors among all clients, regardless of sex and gender, while paying particular attention to muscle dysmorphia and excessive exercise [41].

We also found that adolescents with disordered eating behaviors also had higher rates of elevated anxiety and depressive symptoms than their peers who were not flagged with disordered eating behaviors. Moreover, having elevated anxiety and depressive symptoms at baseline was a significant predictor of more severe disordered eating behaviors among youths flagged with disordered eating behaviors. In children, adolescents, and adults, internalizing disorders such as anxiety and depression frequently co-occur with disordered eating behaviors and EDs [45-47]. This study sample exhibited higher rates of anxiety and depressive symptom comorbidity than previously reported. This is to be expected, given that all children and adolescents in this study were treatment-seeking, whereas previous estimates have included both treatment- and nontreatment-seeking individuals [45,46]. Notably, 95.9% (n=162) of members flagged with disordered eating behaviors participated in care programs other than the body image care program (namely, the anxiety and depression programs), and this group exhibited improvements in disordered eating behaviors, nonetheless. This finding adds to the body of literature suggesting that the overlap between disordered eating behaviors and internalizing problems such as anxiety and depression may have similar underlying constructs and thus may warrant similar treatment [45,48]. Further research is necessary to study the effectiveness of DMHIs in directly addressing disordered eating behaviors as well as treating comorbid EDs and internalizing problems among young people.

Limitations and Future Directions

While our findings provide compelling evidence that participation in a collaborative care DMHI may be associated with improvements in disordered eating behaviors, there are several limitations. The SCOFF assessment has attracted criticism for lack of sensitivity and accuracy and other questionnaires. The Eating Attitudes Test [49], for instance, may indeed allow for more fine-grained assessment and diagnosis of eating behaviors. However, the SCOFF has been used and validated extensively as a screener and assessment of common EDs among adolescents [27,50,51]. Moreover, the SCOFF has a high correlation with other validated disordered eating surveys [52] and has also shown acceptable convergent validity when compared to clinical interviews [53].

It should be noted that the SCOFF questionnaire includes an item that may not be appropriate for adolescents. Adolescence is a time of puberty and rapid growth, and therefore, losing 14 pounds may indicate extreme weight loss and a significant health issue (more so than the other SCOFF items). Further, if an adolescent responds “yes” to this item at one time point, it is unlikely that they will respond “yes” in the next several months. Therefore, we investigated whether our findings were driven or altered by the inclusion of this potentially problematic item. We found that few participants in the study sample responded “yes” to this item (n=44, 7.3% at baseline), and follow-up analyses revealed that our longitudinal results did not substantively change when this item was removed from the calculation of SCOFF scores (Multimedia Appendix 2). Thus, the inclusion of this item did not confound the primary findings reported here.

Although we evaluated cross-sectional associations between improvements in disordered eating behaviors and internalizing problems at baseline, future research should explore longitudinal and bidirectional associations between disordered eating symptoms and changes in mental health symptoms among youths involved in collaborative care DMHIs. Extant research regarding causal associations between disordered eating behaviors and other psychiatric symptoms among those engaged in treatment has yielded heterogeneous results [54-56], but no relevant studies to date have been conducted among youths involved in a collaborative care DMHI.

Concluding Remarks

Young people today are exhibiting increasing rates of disordered eating behaviors and EDs alongside other mental and behavioral problems such as anxiety and depression. Collaborative care DMHIs have the capacity to mitigate the growing mental health crisis by providing holistic and evidence-based care that is more accessible and scalable than traditional modalities. The findings from this study suggest that participation with a collaborative care DMHI such as Bend Health Inc may be beneficial in the reduction of disordered eating symptoms in adolescents. Future studies, particularly those bolstered by improved measurement of eating behaviors over time and with a larger and more diverse cohort of youths, are paramount to establishing the effectiveness of collaborative care DMHIs as an evidence-based provider of care for those with problematic eating behaviors and EDs.

Data Availability

The data sets generated and analyzed during this study are not publicly available because this would violate Bend Health Inc’s privacy. However, aggregated and anonymized data are available from the corresponding author on reasonable request.

Authors' Contributions

LGH wrote the first draft of the paper and led further editing and paper refinement. DL-S performed formal data analysis and generated tables and figures for the paper. ABB wrote the first draft of the paper. JH supervised all paper writing and data analysis. All authors were involved in study conceptualization, development of methodology, and reviewing and editing the paper.

Conflicts of Interest

All authors are employed by, contracted with, or volunteering for Bend Health Inc, which delivered the treatment used in this retrospective study. However, authors’ employment status, salary, and any associated compensation are not dependent upon the results of their research.

Multimedia Appendix 1

Information on the race and ethnicity demographic response options, and also how these data were analyzed.

DOCX File , 13 KB

Multimedia Appendix 2

Additional analyses, and accompanying results, to determine SCOFF response patterns of participants. Follow-up analyses were performed with the response to item 3 excluded from calculations of total SCOFF score.

DOCX File , 16 KB

  1. Galmiche M, Déchelotte P, Lambert G, Tavolacci MP. Prevalence of eating disorders over the 2000-2018 period: a systematic literature review. Am J Clin Nutr. May 01, 2019;109(5):1402-1413. [FREE Full text] [CrossRef] [Medline]
  2. Le Grange D, Swanson SA, Crow SJ, Merikangas KR. Eating disorder not otherwise specified presentation in the US population. Int J Eat Disord. 2012;45(5):711-718. [FREE Full text] [CrossRef] [Medline]
  3. Sim LA, McAlpine DE, Grothe KB, Himes SM, Cockerill RG, Clark MM. Identification and treatment of eating disorders in the primary care setting. Mayo Clin Proc. 2010;85(8):746-751. [FREE Full text] [CrossRef] [Medline]
  4. Swanson SA, Crow SJ, Le Grange D, Swendsen J, Merikangas KR. Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry. 2011;68(7):714-723. [FREE Full text] [CrossRef] [Medline]
  5. Weaver L, Liebman R. Assessment of anorexia nervosa in children and adolescents. Curr Psychiatry Rep. 2011;13(2):93-98. [FREE Full text] [CrossRef] [Medline]
  6. López-Gil JF, García-Hermoso A, Smith L, Firth J, Trott M, Mesas AE, et al. Global proportion of disordered eating in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2023;177(4):363-372. [FREE Full text] [CrossRef] [Medline]
  7. Norris ML, Spettigue WJ, Katzman DK. Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth. Neuropsychiatr Dis Treat. 2016;12:213-218. [FREE Full text] [CrossRef] [Medline]
  8. Hornberger LL, Lane MA, Committee on Adolescence. Identification and management of eating disorders in children and adolescents. Pediatrics. 2021;147(1):e2020040279. [FREE Full text] [CrossRef] [Medline]
  9. Hartman-Munick SM, Lin JA, Milliren CE, Braverman PK, Brigham KS, Fisher MM, et al. Association of the COVID-19 pandemic with adolescent and young adult eating disorder care volume. JAMA Pediatr. 2022;176(12):1225-1232. [FREE Full text] [CrossRef] [Medline]
  10. Termorshuizen JD, Watson HJ, Thornton LM, Borg S, Flatt RE, MacDermod CM, et al. Early impact of COVID-19 on individuals with self-reported eating disorders: a survey of ~1,000 individuals in the United States and the Netherlands. Int J Eat Disord. 2020;53(11):1780-1790. [CrossRef] [Medline]
  11. Deloitte Access Economics; Paxton SJ. Paying the Price: The Economic and Social Impact of Eating Disorders in Australia. Sydney, Australia. Butterfly Foundation; 2012.
  12. Toulany A, Wong M, Katzman DK, Akseer N, Steinegger C, Hancock-Howard RL, et al. Cost analysis of inpatient treatment of anorexia nervosa in adolescents: hospital and caregiver perspectives. CMAJ Open. 2015;3(2):E192-E197. [FREE Full text] [CrossRef] [Medline]
  13. Weissman RS, Rosselli F. Reducing the burden of suffering from eating disorders: unmet treatment needs, cost of illness, and the quest for cost-effectiveness. Behav Res Ther. 2017;88:49-64. [CrossRef] [Medline]
  14. Kazdin AE, Fitzsimmons-Craft EE, Wilfley DE. Addressing critical gaps in the treatment of eating disorders. Int J Eat Disord. 2017;50(3):170-189. [FREE Full text] [CrossRef] [Medline]
  15. Linardon J, Shatte A, Messer M, Firth J, Fuller-Tyszkiewicz M. E-mental health interventions for the treatment and prevention of eating disorders: an updated systematic review and meta-analysis. J Consult Clin Psychol. 2020;88(11):994-1007. [CrossRef] [Medline]
  16. Loucas CE, Fairburn CG, Whittington C, Pennant ME, Stockton S, Kendall T. E-therapy in the treatment and prevention of eating disorders: a systematic review and meta-analysis. Behav Res Ther. 2014;63:122-131. [FREE Full text] [CrossRef] [Medline]
  17. Doyle AC, Goldschmidt A, Huang C, Winzelberg AJ, Taylor CB, Wilfley DE. Reduction of overweight and eating disorder symptoms via the internet in adolescents: a randomized controlled trial. J Adolesc Health. 2008;43(2):172-179. [FREE Full text] [CrossRef] [Medline]
  18. Heinicke BE, Paxton SJ, McLean SA, Wertheim EH. Internet-delivered targeted group intervention for body dissatisfaction and disordered eating in adolescent girls: a randomized controlled trial. J Abnorm Child Psychol. 2007;35(3):379-391. [CrossRef] [Medline]
  19. Jones M, Luce KH, Osborne MI, Taylor K, Cunning D, Doyle AC, et al. Randomized, controlled trial of an internet-facilitated intervention for reducing binge eating and overweight in adolescents. Pediatrics. 2008;121(3):453-462. [CrossRef] [Medline]
  20. Hellner M, Bohon C, Kolander S, Parks E. Virtually delivered family-based eating disorder treatment using an enhanced multidisciplinary care team: a case study. Clin Case Rep. 2021;9(6):e04173. [FREE Full text] [CrossRef] [Medline]
  21. Steinberg D, Perry T, Freestone D, Bohon C, Baker JH, Parks E. Effectiveness of delivering evidence-based eating disorder treatment via telemedicine for children, adolescents, and youth. Eat Disord. 2023;31(1):85-101. [FREE Full text] [CrossRef] [Medline]
  22. Steinberg DM, Perry TR, Freestone D, Hellner M, Baker JH, Bohon C. Evaluating differences in setting expected body weight for children and adolescents in eating disorder treatment. Int J Eat Disord. 2023;56(3):595-603. [FREE Full text] [CrossRef] [Medline]
  23. Hollis C, Falconer CJ, Martin JL, Whittington C, Stockton S, Glazebrook C, et al. Annual research review: digital health interventions for children and young people with mental health problems—a systematic and meta-review. J Child Psychol Psychiatry. 2017;58(4):474-503. [CrossRef] [Medline]
  24. Huffman LG, Lawrence-Sidebottom D, Huberty J, Roots M, Roots K, Parikh A, et al. Using digital measurement-based care for the treatment of anxiety and depression in children and adolescents: observational retrospective analysis of Bend Health Data. JMIR Pediatr Parent. 2023;6:e46154. [FREE Full text] [CrossRef] [Medline]
  25. Lawrence-Sidebottom D, Huffman LG, Huberty J, Beatty C, Roots M, Roots K, et al. Using digital measurement-based care to address symptoms of inattention, hyperactivity, and opposition in youth: retrospective analysis of bend health. JMIR Form Res. 2023;7:e46578. [FREE Full text] [CrossRef] [Medline]
  26. Richardson LP, McCarty CA, Radovic A, Suleiman AB. Research in the integration of behavioral health for adolescents and young adults in primary care settings: a systematic review. J Adolesc Health. 2017;60(3):261-269. [FREE Full text] [CrossRef] [Medline]
  27. Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire. West J Emerg Med. 2000;172(3):164. [CrossRef]
  28. Rueda GE, Díaz LA, Campo A, Barros JA, Avila GC, Oróstegui LT, et al. Validación de la encuesta SCOFF para tamizaje de trastornos de la conducta alimentaria en mujeres universitarias [Validation of the SCOFF questionnaire for screening of eating disorders in university women]. Biomedica. 2005;25(2):196-202. [Medline]
  29. DSM-5-TR self-rated level 1 cross-cutting symptom measure—child age 11-17. American Psychiatric Association. 2013. URL: https:/​/www.​psychiatry.org/​getmedia/​9352851c-d69f-411a-8933-3212e8c29063/​APA-DSM5TR-Level1MeasureChildAge11To17.​pdf [accessed 2024-01-05]
  30. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. [FREE Full text] [CrossRef] [Medline]
  31. Tiirikainen K, Haravuori H, Ranta K, Kaltiala-Heino R, Marttunen M. Psychometric properties of the 7-item Generalized Anxiety Disorder Scale (GAD-7) in a large representative sample of Finnish adolescents. Psychiatry Res. 2019;272:30-35. [CrossRef] [Medline]
  32. Johnson JG, Harris ES, Spitzer RL, Williams JBW. The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196-204. [CrossRef] [Medline]
  33. López-Torres S, Pérez-Pedrogo C, Sánchez-Cardona I, Sánchez-Cesáreo M. Psychometric properties of the PHQ-A among a sample of children and adolescents in Puerto Rico. Curr Psychol. 2019;41(1):90-98. [CrossRef]
  34. Chadi N, Spinoso-Di Piano C, Osmanlliu E, Gravel J, Drouin O. Mental health-related emergency department visits in adolescents before and during the COVID-19 pandemic: a multicentric retrospective study. J Adolesc Health. 2021;69(5):847-850. [FREE Full text] [CrossRef] [Medline]
  35. Weissman RS, Bauer S, Thomas JJ. Access to evidence-based care for eating disorders during the COVID-19 crisis. Int J Eat Disord. 2020;53(5):369-376. [FREE Full text] [CrossRef] [Medline]
  36. Boulé CJ, McSherry JA. Patients with eating disorders. How well are family physicians managing them? Can Fam Physician. 2002;48:1807-1813. [FREE Full text] [Medline]
  37. Clarke DE, Polimeni-Walker I. Treating individuals with eating disorders in family practice: a needs assessment. Eat Disord. 2004;12(4):293-301. [CrossRef] [Medline]
  38. Kraus B, Stronski S, Michaud P. Training needs in adolescent medicine of practising doctors: a Swiss national survey of six disciplines. Med Educ. 2003;37(8):709-714. [CrossRef] [Medline]
  39. Williamson DA, Martin CK, Stewart T. Psychological aspects of eating disorders. Best Pract Res Clin Gastroenterol. 2004;18(6):1073-1088. [CrossRef] [Medline]
  40. Eating disorders. National Institute of Mental Health. URL: https://www.nimh.nih.gov/health/statistics/eating-disorders [accessed 2023-11-01]
  41. Thompson D. Boys and men get eating disorders too. Trends Urol Mens Health. 2022;13(2):28-32. [FREE Full text] [CrossRef]
  42. Anderson CB, Bulik CM. Gender differences in compensatory behaviors, weight and shape salience, and drive for thinness. Eat Behav. 2004;5(1):1-11. [CrossRef] [Medline]
  43. Coelho JS, Suen J, Marshall S, Burns A, Geller J, Lam PY. Gender differences in symptom presentation and treatment outcome in children and youths with eating disorders. J Eat Disord. 2021;9(1):113. [FREE Full text] [CrossRef] [Medline]
  44. Tod D, Edwards C, Cranswick I. Muscle dysmorphia: current insights. Psychol Res Behav Manag. 2016;9:179-188. [FREE Full text]
  45. Kambanis PE, Kuhnle MC, Wons OB, Jo JH, Keshishian AC, Hauser K, et al. Prevalence and correlates of psychiatric comorbidities in children and adolescents with full and subthreshold avoidant/restrictive food intake disorder. Int J Eat Disord. 2020;53(2):256-265. [FREE Full text] [CrossRef] [Medline]
  46. Micali N, Ploubidis G, De Stavola B, Simonoff E, Treasure J. Frequency and patterns of eating disorder symptoms in early adolescence. J Adolesc Health. 2014;54(5):574-581. [FREE Full text] [CrossRef] [Medline]
  47. Ulfvebrand S, Birgegård A, Norring C, Högdahl L, von Hausswolff-Juhlin Y. Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Res. 2015;230(2):294-299. [CrossRef] [Medline]
  48. Forbush KT, Hagan KE, Kite BA, Chapa DAN, Bohrer BK, Gould SR. Understanding eating disorders within internalizing psychopathology: a novel transdiagnostic, hierarchical-dimensional model. Compr Psychiatry. 2017;79:40-52. [CrossRef] [Medline]
  49. Garner DM, Garfinkel PE. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med. 1979;9(2):273-279. [CrossRef] [Medline]
  50. Cerniglia L, Cimino S. Eating disorders and internalizing/externalizing symptoms in adolescents before and during the COVID-19 pandemic. J Am Nutr Assoc. 2023;42(5):445-451. [CrossRef] [Medline]
  51. Giel KE, Zipfel S, Schweizer R, Braun R, Ranke MB, Binder G, et al. Eating disorder pathology in adolescents participating in a lifestyle intervention for obesity: associations with weight change, general psychopathology and health-related quality of life. Obes Facts. 2013;6(4):307-316. [FREE Full text] [CrossRef] [Medline]
  52. Noma S, Nakai Y, Hamagaki S, Uehara M, Hayashi A, Hayashi T. Comparison between the SCOFF questionnaire and the eating attitudes test in patients with eating disorders. Int J Psychiatry Clin Pract. 2006;10(1):27-32. [CrossRef] [Medline]
  53. Hill LS, Reid F, Morgan JF, Lacey JH. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord. 2010;43(4):344-351. [CrossRef] [Medline]
  54. Kim SK, Annunziato RA. Can eating disorder treatment also alleviate psychiatric comorbidity? Matched correspondence analysis. Psychother Psychosom. 2020;89(2):125-127. [CrossRef] [Medline]
  55. Lydecker JA, Grilo CM. Psychiatric comorbidity as predictor and moderator of binge-eating disorder treatment outcomes: an analysis of aggregated randomized controlled trials. Psychol Med. 2021:1-9. [FREE Full text] [CrossRef] [Medline]
  56. O'Brien KM, Vincent NK. Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clin Psychol Rev. 2003;23(1):57-74. [CrossRef] [Medline]


BCM: behavioral care manager
DMHI: digital mental health intervention
DSM-5-TR: Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition, Text Revision
ED: eating disorder
GAD-7: Generalized Anxiety Disorder-7
PHQ-9A: Patient Health Questionnaire-9 for Adolescents


Edited by A Mavragani; submitted 02.11.23; peer-reviewed by Y Yang; comments to author 30.11.23; revised version received 14.12.23; accepted 28.12.23; published 31.01.24.

Copyright

©Landry Goodgame Huffman, Darian Lawrence-Sidebottom, Aislinn Brenna Beam, Amit Parikh, Rachael Guerra, Monika Roots, Jennifer Huberty. Originally published in JMIR Formative Research (https://formative.jmir.org), 31.01.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.